|
TCEB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.648100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.137810E-01 |
| Normal-vs-Stage2 |
9.680400E-02 |
| Normal-vs-Stage3 |
7.415500E-04 |
| Normal-vs-Stage4 |
1.742850E-03 |
| Stage1-vs-Stage2 |
3.332800E-01 |
| Stage1-vs-Stage3 |
8.677700E-02 |
| Stage1-vs-Stage4 |
2.206200E-02 |
| Stage2-vs-Stage3 |
9.030200E-01 |
| Stage2-vs-Stage4 |
5.614200E-01 |
| Stage3-vs-Stage4 |
3.090600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.020800E-03 |
| Normal-vs-AfricanAmerican |
1.554970E-04 |
| Normal-vs-Asian |
2.850400E-01 |
| Caucasian-vs-AfricanAmerican |
3.656700E-03 |
| Caucasian-vs-Asian |
4.062000E-01 |
| AfricanAmerican-vs-Asian |
6.324200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.858100E-03 |
| Normal-vs-Female |
1.799720E-03 |
| Male-vs-Female |
7.912600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.027500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.809590E-02 |
| Normal-vs-Age(61-80Yrs) |
5.357600E-03 |
| Normal-vs-Age(81-100Yrs) |
9.504200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.608200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.474600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.894400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.867400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.261200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.003600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.265600E-01 |
| Normal-vs-Grade 2 |
2.130800E-01 |
| Normal-vs-Grade 3 |
6.06920000000288E-05 |
| Normal-vs-Grade 4 |
9.157800E-04 |
| Grade 1-vs-Grade 2 |
5.802800E-01 |
| Grade 1-vs-Grade 3 |
1.982220E-01 |
| Grade 1-vs-Grade 4 |
3.765600E-02 |
| Grade 2-vs-Grade 3 |
5.603600E-02 |
| Grade 2-vs-Grade 4 |
3.040000E-02 |
| Grade 3-vs-Grade 4 |
2.718200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.844200E-01 |
| Normal-vs-ccB subtype |
4.218100E-02 |
| ccA subtype-vs-ccB subtype |
1.922130E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.536320E-02 |
| Normal-vs-N1 |
1.435430E-01 |
| N0-vs-N1 |
6.848800E-01 |
|
|
